Abstract

Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device

Author(s): Tsiouris Maria, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min

Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide

Page(s): 436-439

Download in electronic PDF format for $75
  • Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Page 1
  • Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Page 2
  • Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Page 3
  • Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Page 4

Abstract

The stability and compatibility of caspofungin acetate reconstituted in 0.9% sodium chloride injection was studied in select elastomeric infusion devices. Caspofungin acetate solutions at three different concentrations, 0.2, 0.28, and 0.5 mg/mL, were stored in three commonly used elastomeric infusion devices at 5°C ± 3°C and at room temperature. Sample mixtures of the drug were tested for stability every 12 hours (60 hours maximum) at room temperature, every 24 hours (72 hours maximum), and at 8, 9, and 14 days under refrigerated conditions (5°C ± 3°C). Samples were assayed by using a high-performance liquid chromatographic method. The reconstituted caspofungin solutions maintained =90% of the original active concentration for the duration of this study under both storage conditions. Degradation product levels remained within historical limits throughout the course of this study. Furthermore, the initial concentration of the caspofungin solutions was found to have no effect on the study results.

Related Keywords

  • reconstituted caspofungin
  • antifungal agent
  • fungal infection
  • stability
  • compatibility
  • elastomeric infusion devices
  • storage conditions

Related Categories

  • INFUSION
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • QUALITY CONTROL
  • INFECTIOUS DISEASE
  • STORAGE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2010
Pg. 436-439
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device
Author(s): Tsiouris Maria, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min
May/Jun 2011
Pg. 252-254
Stability of Ertapenem in an Elastomeric Infusion Device
Author(s): Phipps Stephen D, Peacock Gina F, Smith Douglas L
Sep/Oct 2015
Pg. 432-436
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Author(s): Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
Jul/Aug 2016
Pg. 343-346
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Author(s): Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
May/Jun 2008
Pg. 276-278
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 94-100
Home Infusion Basics for the Non-Infusion Pharmacist
Author(s): Miron Karen E
May/Jun 2011
Pg. 183-188
Home Infusion: Available Vascular Access Devices and Common Therapies
Author(s): Kennedy Steve, Williams LaVonn A
Jul/Aug 2000
Pg. 281-285
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Author(s): Ashworth Lisa D
Sep/Oct 2018
Pg. 417-423
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags
Author(s): Nalenz Heiko, Köpf Ellen, Dietel Elke
Nov/Dec 2011
Pg. 515-520
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags
Author(s): Kaiser Jeanette, Kramer Irene
Mar/Apr 2008
Pg. 156-160
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2000
Pg. 442-443
Disposable Ambulatory Infusion Devices: A Review - Part 3
Author(s): Ashworth Lisa D
Sep/Oct 2000
Pg. 364
Ambulatory Syringe Infusion Devices: A Review - Part 2
Author(s): Ashworth Lisa D
Mar/Apr 2002
Pg. 152-154
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags
Author(s): Xu Quanyun A, Trissel Lawrence A, Saenz Christopher A, Ingram Delshalonda S
Mar/Apr 2003
Pg. 152-154
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Author(s): Gupta Vishnu D
Mar/Apr 2004
Pg. 156-159
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags
Author(s): Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004
Pg. 153-155
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion
Author(s): Gupta Vishnu D
Sep/Oct 2014
Pg. 427-431
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard